Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Start Date
12/23/2024
Completion Date
7/1/2041
Summary
This LTFU is being conducted to assess long-term safety and durability of response in participants dosed with IP in a parent protocol, and to collect longitudinal natural history in enrolled but not dosed participants who also participated in a parent protocol.
Detailed Description
This is a 14.5 year LTFU protocol to assess long term safety and clinical response to IP as well as to capture natural disease history of participants not dosed with IP in a parent protocol. No IP is provided as part of this protocol. Participants will remain on standard of care medication as indicated and prescribed by their physicians.
Eligibility Criteria
Age Range: No minimum to No maximum
Interventions
No Intervention
Conditions
Locations
Children's Hospital of Colorado, Anshutz Medical Campus
Aurora, Colorado 80045
United States
Icahn School of Medicine at Mount Sinai
New York, New York 10029
United States
Great Ormond Street Hospital
London,
United Kingdom